Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 209942
Company: TEVA PHARMS USA
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ALYQ TADALAFIL 20MG TABLET;ORAL Prescription AB2 No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/05/2019 ORIG-1 Approval STANDARD

Label is not available on this site.

ALYQ

TABLET;ORAL; 20MG
TE Code = AB2

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ADCIRCA TADALAFIL 20MG TABLET;ORAL Prescription Yes AB2 022332 ELI LILLY CO
ALYQ TADALAFIL 20MG TABLET;ORAL Prescription No AB2 209942 TEVA PHARMS USA
TADALAFIL TADALAFIL 20MG TABLET;ORAL Prescription No AB2 210392 AJANTA PHARMA LTD
TADALAFIL TADALAFIL 20MG TABLET;ORAL Prescription No AB2 206286 AUROBINDO PHARMA LTD
TADALAFIL TADALAFIL 20MG TABLET;ORAL Prescription No AB2 210255 CIPLA
TADALAFIL TADALAFIL 20MG TABLET;ORAL Prescription No AB2 210145 DR REDDYS LABS LTD
TADALAFIL TADALAFIL 20MG TABLET;ORAL Prescription No AB2 209907 HETERO LABS LTD III
TADALAFIL TADALAFIL 20MG TABLET;ORAL Prescription No AB2 210572 LUPIN LTD
TADALAFIL TADALAFIL 20MG TABLET;ORAL Prescription No AB2 200630 MYLAN PHARMS INC

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English